ID15858A - TRIAZOL DERIVES USED IN THERAPY - Google Patents

TRIAZOL DERIVES USED IN THERAPY

Info

Publication number
ID15858A
ID15858A IDP970289A ID970289A ID15858A ID 15858 A ID15858 A ID 15858A ID P970289 A IDP970289 A ID P970289A ID 970289 A ID970289 A ID 970289A ID 15858 A ID15858 A ID 15858A
Authority
ID
Indonesia
Prior art keywords
triazol
derives
therapy
triazol derives
derives used
Prior art date
Application number
IDP970289A
Other languages
Indonesian (id)
Inventor
Stuart Green
Peter T Stephenson
Charles W Murtiashaw
Original Assignee
Pfizer Res And Dev Nv Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res And Dev Nv Sa filed Critical Pfizer Res And Dev Nv Sa
Publication of ID15858A publication Critical patent/ID15858A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
    • C07F9/6518—Five-membered rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDP970289A 1996-02-02 1997-01-31 TRIAZOL DERIVES USED IN THERAPY ID15858A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9602080.5A GB9602080D0 (en) 1996-02-02 1996-02-02 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
ID15858A true ID15858A (en) 1997-08-14

Family

ID=10787975

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970289A ID15858A (en) 1996-02-02 1997-01-31 TRIAZOL DERIVES USED IN THERAPY

Country Status (42)

Country Link
US (4) US6790957B2 (en)
EP (1) EP0880533B1 (en)
JP (1) JP2959846B2 (en)
KR (1) KR100283546B1 (en)
CN (1) CN1085213C (en)
AP (1) AP678A (en)
AT (1) ATE219089T1 (en)
AU (1) AU709781B2 (en)
BG (1) BG63946B1 (en)
BR (1) BR9707257A (en)
CA (1) CA2240777C (en)
CO (1) CO4761066A1 (en)
CZ (1) CZ291431B6 (en)
DE (1) DE69713284T2 (en)
DK (1) DK0880533T3 (en)
DZ (1) DZ2172A1 (en)
ES (1) ES2175336T3 (en)
GB (1) GB9602080D0 (en)
GT (1) GT199700016A (en)
HN (1) HN1997000012A (en)
HR (1) HRP970063B1 (en)
HU (1) HU226133B1 (en)
ID (1) ID15858A (en)
IL (3) IL124865A (en)
IS (1) IS1995B (en)
MY (1) MY116849A (en)
NO (1) NO323771B1 (en)
NZ (1) NZ330654A (en)
OA (1) OA10711A (en)
PL (1) PL187237B1 (en)
PT (1) PT880533E (en)
RS (1) RS49526B (en)
RU (1) RU2176244C2 (en)
SA (1) SA97170578B1 (en)
SI (1) SI0880533T1 (en)
SK (1) SK283136B6 (en)
TN (1) TNSN97023A1 (en)
TR (1) TR199801440T2 (en)
TW (1) TW434247B (en)
UA (1) UA46828C2 (en)
WO (1) WO1997028169A1 (en)
ZA (1) ZA97826B (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602080D0 (en) * 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
GB9713149D0 (en) 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
DE19751525C2 (en) 1997-11-20 2003-02-13 Bat Cigarettenfab Gmbh Method and device for controlling the initial moisture content of tobacco
US6265584B1 (en) 1998-05-22 2001-07-24 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
AU1915500A (en) 1998-11-20 2000-06-13 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6235728B1 (en) 1999-02-19 2001-05-22 Bristol-Myers Squibb Company Water-soluble prodrugs of azole compounds
KR20010050557A (en) 1999-09-29 2001-06-15 타이도 나오카타 Azole derivatives or salts thereof
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6448401B1 (en) * 2000-11-20 2002-09-10 Bristol-Myers Squibb Company Process for water soluble azole compounds
US7540402B2 (en) * 2001-06-29 2009-06-02 Kva, Inc. Method for controlling weld metal microstructure using localized controlled cooling of seam-welded joints
US7323572B2 (en) 2002-07-16 2008-01-29 Pfizer Inc Process for controlling the hydrate mix of a compound
EP1646284A4 (en) * 2003-07-18 2008-09-24 Rhode Island Education AZOL DERIVATIVES AND METHOD FOR THEIR PREPARATION
CA2560843A1 (en) * 2004-03-24 2005-10-06 Fasgen, Llc Novel method of neuroprotection by pharmacological inhibition of amp-activated protein kinase
CN1303073C (en) * 2005-05-31 2007-03-07 中国人民解放军第二军医大学 Substituted triazolone benzyl amine triazole antifungal compounds and method for preparing same
JP5046959B2 (en) * 2005-12-20 2012-10-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 Method for producing water-soluble azole prodrug
PL1968990T3 (en) 2005-12-27 2015-06-30 Otsuka Pharma Co Ltd Water-soluble benzoazepine compound and its pharmaceutical composition
ES2351365T3 (en) 2006-02-22 2011-02-03 EISAI R&D MANAGEMENT CO., LTD. STABILIZED PHARMACEUTICAL COMPOSITION.
KR100889937B1 (en) * 2007-08-06 2009-03-20 한미약품 주식회사 Method of preparing barleyconazole
CN104983701A (en) * 2008-04-15 2015-10-21 默沙东公司 ORAL PHARMACEUTICAL COMPOSITIONS IN A SOLID DISPERSION COMPRISING PREFERABLY POSACONAZOLE AND HPMCAs
CN101575330B (en) * 2008-05-05 2012-10-31 丽珠医药集团股份有限公司 Novel voriconazole broad-spectrum antifungal medicine compound, broad-spectrum antifungal medicine composition and application thereof
WO2011064558A2 (en) 2009-11-30 2011-06-03 Cipla Limited Pharmaceutical composition
EP2723452A2 (en) 2011-06-22 2014-04-30 Vyome Biosciences Pvt Ltd Conjugate-based antifungal and antibacterial prodrugs
EP2561863A1 (en) 2011-08-22 2013-02-27 Farmaprojects, S.A.U. Pharmaceutical compositions comprising voriconazole
EA026209B1 (en) 2012-01-20 2017-03-31 Ваймет Фармасьютикалс, Инк. Metalloenzyme inhibitor compounds
HRP20231151T1 (en) * 2012-03-19 2024-01-05 Cidara Therapeutics, Inc. Dosing regimens for echinocandin class compounds
CN103864844B (en) * 2012-12-09 2016-10-05 正大天晴药业集团股份有限公司 A kind of preparation method of good fortune department Fluconazole
CN103304600B (en) * 2013-03-04 2018-05-25 陕西合成药业股份有限公司 A kind of voriconazole phosphate ester trihydrate and its preparation method and application
EP2968595A2 (en) 2013-03-14 2016-01-20 Fresenius Kabi USA LLC Voriconazole formulations
RU2719579C2 (en) * 2013-03-14 2020-04-21 Сидара Терапьютикс, Инк. Dosing regimens for echinocandin class compounds
US20160128944A1 (en) 2013-06-04 2016-05-12 Vyome Biosciences Pvt. Ltd. Coated particles and compositions comprising same
CN103524560A (en) * 2013-09-28 2014-01-22 陕西合成药业有限公司 Voriconazole sodium diphosphate hydrate and polycrystal forms thereof
CN104650140B (en) * 2013-11-18 2017-11-10 正大天晴药业集团股份有限公司 A kind of preparation method of high-purity good fortune department Fluconazole
MX394441B (en) 2014-01-29 2025-03-24 Vyome Therapeutics Ltd A BESIFLOXACIN-BASED FORMULATION FOR USE IN THE TREATMENT OF DRUG-RESISTANT ACNE
CN104860992A (en) * 2014-02-25 2015-08-26 陕西合成药业股份有限公司 Preparation method of high-purity fosfluconazole
CN105985377A (en) * 2015-02-09 2016-10-05 陕西合成药业股份有限公司 Fosfluconazole salt hydrate and preparation method thereof
CN106279280A (en) * 2015-05-25 2017-01-04 西藏卫信康医药股份有限公司 A kind of compound and its preparation method and application
CN106518922A (en) * 2015-09-12 2017-03-22 陕西合成药业股份有限公司 Triazole compounds, and preparation method and applications thereof
CN106546668A (en) * 2015-09-22 2017-03-29 陕西合成药业股份有限公司 A kind of HPLC methods for separating good fortune department's fluconazole or its pharmaceutical salts about material
CN105237569B (en) * 2015-10-21 2017-07-25 西南科技大学 A kind of synthetic method for preparing 2,4-difluoro-α, α-di(1 hydrogen-1,2,4-triazol-1-ylmethyl) benzyl alcohol dibenzyl phosphate
CN105753902B (en) * 2016-04-11 2017-08-25 浙江诚意药业股份有限公司 A kind of preparation method of good fortune department Fluconazole
CN108676031A (en) * 2018-05-29 2018-10-19 重庆威鹏药业有限公司 Water-soluble triazole antifungal phosphinic acid compounds and its preparation method and application
CN111171075B (en) * 2020-04-03 2022-07-12 北京四环生物制药有限公司 Preparation method of fosfluconazole

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2099818A (en) * 1981-06-06 1982-12-15 Pfizer Ltd Triazoles
US4528284A (en) * 1982-10-15 1985-07-09 Ciba-Geigy Corporation Fungicidal 2-(azolylmethyl-1'-yl)-2-aryl-2-(cyano, alkoxycarbonyl, alkylthiocarbonyl and aminocarbonyl)-2-phosphorus acid esters
US4952232A (en) * 1987-04-29 1990-08-28 E. I. Du Pont De Nemours And Company Antifungal carbinols
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
US5278175A (en) * 1990-02-02 1994-01-11 Pfizer Inc. Triazole antifungal agents
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
TW211006B (en) * 1990-08-24 1993-08-11 Mochida Pharm Co Ltd
TW218017B (en) * 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
US5358939A (en) * 1992-06-25 1994-10-25 Rohm And Haas Company Fungicidal 2-aryl-2,2-disubstituted ethyl-1,2,4-triazoles
NZ278882A (en) * 1994-01-24 1997-06-24 Janssen Pharmaceutica Nv Piperazine-containing azole antifungal compounds
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
HUT74735A (en) * 1994-02-25 1997-02-28 Takeda Chemical Industries Ltd Injectable emulsion composition containing antifungal triazole derivatives and process for producing it
GB9512961D0 (en) * 1995-06-26 1995-08-30 Pfizer Ltd Antifungal agents
FR2741061B1 (en) * 1995-11-13 1998-03-20 Alcatel Fibres Optiques METHOD FOR MANUFACTURING SINGLE-MODE OPTICAL FIBER AND OPTICAL AMPLIFIER USING SUCH FIBER
GB9602080D0 (en) * 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
US5767977A (en) * 1996-12-19 1998-06-16 Hewlett-Packard Co. Method and apparatus for a carriage latch and power cord lock-out system for an optical scanner

Also Published As

Publication number Publication date
IL124865A (en) 2002-03-10
PL187237B1 (en) 2004-06-30
DZ2172A1 (en) 2002-12-01
TNSN97023A1 (en) 2005-03-15
CZ242098A3 (en) 1999-05-12
IL124865A0 (en) 1999-01-26
EP0880533A1 (en) 1998-12-02
RU2176244C2 (en) 2001-11-27
SI0880533T1 (en) 2002-08-31
EP0880533B1 (en) 2002-06-12
SK102298A3 (en) 1999-08-06
SA97170578B1 (en) 2006-01-28
GB9602080D0 (en) 1996-04-03
HU226133B1 (en) 2008-05-28
CO4761066A1 (en) 1999-04-27
CA2240777A1 (en) 1997-08-07
IL133135A0 (en) 2001-03-19
OA10711A (en) 2001-06-04
WO1997028169A1 (en) 1997-08-07
DE69713284D1 (en) 2002-07-18
SK283136B6 (en) 2003-03-04
HRP970063A2 (en) 1998-06-30
CN1210540A (en) 1999-03-10
KR19990082233A (en) 1999-11-25
PT880533E (en) 2002-09-30
DE69713284T2 (en) 2003-03-27
JPH10512599A (en) 1998-12-02
US20040236105A1 (en) 2004-11-25
HN1997000012A (en) 1997-06-26
CZ291431B6 (en) 2003-03-12
US6977302B2 (en) 2005-12-20
BR9707257A (en) 1999-04-06
TW434247B (en) 2001-05-16
GT199700016A (en) 1998-07-24
BG102603A (en) 1999-03-31
PL328436A1 (en) 1999-02-01
MY116849A (en) 2004-04-30
ZA97826B (en) 1998-07-31
ES2175336T3 (en) 2002-11-16
YU2997A (en) 2000-10-30
DK0880533T3 (en) 2002-07-15
AP9700923A0 (en) 1997-01-31
NO983560D0 (en) 1998-08-03
UA46828C2 (en) 2002-06-17
ATE219089T1 (en) 2002-06-15
RS49526B (en) 2006-12-15
HUP9900949A3 (en) 2001-08-28
AP678A (en) 1998-09-28
IL133135A (en) 2003-07-06
JP2959846B2 (en) 1999-10-06
HRP970063B1 (en) 2001-12-31
NZ330654A (en) 1999-08-30
TR199801440T2 (en) 1998-10-21
US20070027115A1 (en) 2007-02-01
KR100283546B1 (en) 2001-04-02
NO323771B1 (en) 2007-07-02
US20030144250A1 (en) 2003-07-31
HUP9900949A2 (en) 2001-05-28
US20050130940A1 (en) 2005-06-16
IS4785A (en) 1998-06-26
CA2240777C (en) 2002-06-11
BG63946B1 (en) 2003-07-31
AU1598597A (en) 1997-08-22
AU709781B2 (en) 1999-09-09
US6790957B2 (en) 2004-09-14
HK1018217A1 (en) 1999-12-17
CN1085213C (en) 2002-05-22
IS1995B (en) 2005-03-15
NO983560L (en) 1998-08-03

Similar Documents

Publication Publication Date Title
NO983560D0 (en) Triazole derivatives useful in therapy
FI970762L (en) Spiroazabicyclic compounds useful in therapy
GB9609641D0 (en) Compounds useful in therapy
NO983266D0 (en) Distributed Treatment
ID28981A (en) HEKSANA 3-AZABISIKLO (3.1.0) USES IN THERAPY
GB9601724D0 (en) Therapeutic agents
NO992806L (en) Therapeutic agents
GB9600235D0 (en) Therapeutic agents
NO983263L (en) Distributed treatment
FI971193A7 (en) Quinoxaline derivatives useful in therapy
GB9609374D0 (en) Therapeutic agents
GB9620777D0 (en) Therapeutic use
ID19871A (en) QUINOXOXINE DEPOSITS USED IN THERAPY
GB9610979D0 (en) Therapeutic agents
GB9604036D0 (en) Therapeutic agents
MD281F1 (en) Magnetodynamic massage
GB9615658D0 (en) Therapeutic agents
SE9602645D0 (en) Azabicyclic derivatives useful in therapy
GB9609894D0 (en) Portable sauna
SI1011649T1 (en) Use of endipalene in the treatment of psoriasis
BR7601298U (en) Constructive arrangement in residential sauna
BR7401857U (en) Arrangement introduced in chair
GB9605465D0 (en) Therapeutic use
GB9620880D0 (en) Therapeutic use
GB9605523D0 (en) Therapeutic use